CLDN1 and neoplasm: Endoscopic imaging was performed on each mouse on days 5, 8, and 12 following DSS administration, which showed increased inflammation and tumor development as early as day-5 post DSS-administration in APC-Cldn1 mice (Figure 2A) compared to APCMin mice where colon tumor appeared around day-8.